June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Clinical utility of SD-OCT -Enhanced Depth Imaging in Evaluation of Retinal and Choroidal Tumors of the Human Eye
Author Affiliations & Notes
  • Peter Hovland
    Colorado Retina Associates, Denver, CO
  • Footnotes
    Commercial Relationships Peter Hovland, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5897. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Peter Hovland; Clinical utility of SD-OCT -Enhanced Depth Imaging in Evaluation of Retinal and Choroidal Tumors of the Human Eye. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5897.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To present illustrative examples of clinical cases in which the use of the Heidelberg Spectralis instrument created uniquely useful images which allow for the precise determination of diagnosis, anatomic localization and dimension, and local tissue effects of intraocular tumors.

Methods: A non-randomized series of patients presenting to an ocular oncology clinic were selected for testing with the Heidelberg Spectralis instrument on the EDI-OCT setting. Correlation with clinical history was applied to the interpretation of the images. EDI-OCT images were obtained of CHRPE, choroidal nevus, treatment naive choroidal melanoma, treated choroidal melanoma (status-post brachytherapy, diode laser, intravitreal bevacizumab and/or argon laser), and metastatic choroidal and retinal lesions.

Results: In an analysis of over 50 patients, the EDI-OCT could precisely determine the depth of the lesions when the maximal depth did not exceed 2 mm. For choroidal lesions, overlying tissue changes of the retina could be described in terms of presence or absence of subretinal fluid, photoreceptor changes, retinal edema or degeneration, and RPE abnormalities. Changes in these tissue elements can be followed over time as a means of surveillance to monitor for evidence of neoplasm, or response to treatment.

Conclusions: The EDI-OCT provides an extremely useful adjunct to standard techniques in the work-up and surveillance of ocular oncology patients, and especially so for the monitoring of smaller suspicious lesions.

Keywords: 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • 744 tumors • 580 lesion study  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.